Synaffix BV
- Biotech or pharma, therapeutic R&D
Synaffix has established a proprietary, clinical-stage platform antibody-drug conjugate (ADC) technology that delivers superior safety and efficacy compared to all 3 major clinical-stage ADC technologies. Our business model is technology out-licensing.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}